Pain, jaundice and loss of weight are the most frequent presenting symptoms of cancer of the pancreas. Jaundice can be relieved by surgical intervention and this will increase the length of survival of patients. However, pain occurs at some time during the course of the illness in 80 % -of patients and, when it occurs at an early stage of the disease, it persists not only as a major symptom but as an ominous sign (Braganza & Howat 1972) . The use of intra-arterial chemotherapy primarily for the relief of pain has been explored in this neoplasm and those of the liver, biliary tree and gall-bladder.
Method
During the period 1968-73, a selected series of 112 patients with upper gastrointestinal neoplasms have been treated by percutaneous femoral intra-arterial cceliac axis infusion with anticancer drugs. The technique used consists essentially of inserting an arterial catheter, as for a coeliac angiogram, but placing the tip preferentially into the common hepatic artery. The catheter is then connected to a constant infusion pump (Gazet 1973) . The catheter may require adjustment, and this is the most frequent complication. 5-fluorouracil (5-FU) has been the drug of choice in a dose of 15 mg/kg per day or I g/day (whichever is the greater dose) for a period of five days. Each 0.5 g of 5-FU is added to 500 ml of normal saline containing 500 units of heparin and infused over 12 hours. In the last 23 infusions, pulsed doses of I g cyclophosphamide, 2 mg vincristine and 50 mg methotrexate have been added.
Usually prophylactic ampicillin 250 mg 6 hourly for 5 days has been given at the same time. Following catheter removal, intravenous maintenance therapy of 1 g of 5-FU has been given weekly when possible for three months. In some patients a second infusion has been given. Only 3 patients have had toxic symptoms from drug therapy. All patients have had preand postinfusion liver function tests, repeated thereafter as appropriate. A full blood count has been performed pre-infusion, daily during infusion. and twice weekly thereafter for two weeks, then once weekly during intravenous therapy.
Results
Of 65 patients who had pancreatic carcinoma 14 were noted to have secondary deposits in the liver at the time of exploration. All were incurable. Six patients had a previous palliative resection and now had recurrent disease. Of the patients referred for a second opinion, 20 had a further exploration, but of these only 3 had a palliative procedure performed. By 31 December 1973, 53 had died, 12 were still alive.
Survival in the 53 patients now dead has varied from 4 to 944 days infusion with a median survival of 143 days and mean survival of 192 days. The survival from the date of operation or proof of incurability has varied from 20 to 964 days with a median survival of 196 days and mean survival of 265 days. Pain was a primary symptom in 46 of these patients, and was graded arbitrarily on a scale of 0-10; no pain was equal to zero (0) and intolerable pain was given a score of 10 (T F R Pilkington 1969, personal communication). All scored the severity of pain pre-infusion above 5 (intolerable pain). At one week from the commencement of treatment, the severity of pain was less. By one to three months after treatment, there was a tendency for the severity of the pain to increase or recur. This has been calculated alternatively as the percentage of patients suffering intolerable (5 +) or tolerable (5-) pain in the three periods noted. At one week post-infusion 66% had tolerable and 34% intolerable pain; whereas at 1-3 months post-infusion, the ratio was 50 % each group. Taking complete or mark7ed improvement in pain as a group, then 54.1 % of patients had a worth-while relief of symptoms with a recurrence of pain in less than a third of the group. In other words, 37.5 % of patients with intolerable pain had complete and permanent relief of symptoms until death. At 31.12.73, 12 patients had survived from 28 to 1297 days. In 8 the primary symptom was pain; one patient had a marked improvement of symptoms and 5 others had some benefit.
Conclusions
Despite isolated reports on the disappearance of hepatic cancer after intra-arterial chemotherapy (Anderson et al. 1972 Proximal gastric vagotomy (PGV) results in the division of the branches of the vagus that pass to the body of the stomach. The body of the stomach is lined by mucosa which contains acid-secreting parietal cells. All other branches of the vagus nerve are preserved, including those that pass to the antrum, pylorus and duodenum. A consecutive series of 100 men with uncomplicated chronic duodenal ulcer has been prospectively randomized into two groups. In the first, of 52 men, PGV was performed and in the second, of 48 men, PGV with a modified form of Finney pyloroplasty (PGV +P) was carried out.
It is not the purpose of this paper to describe the technique of PGV in detail but two points will be made. The first is that adequate exposure is essential and we have found that a 4 bladed ring retractor is essential (Fig 1A, B) . The second is that for all patients in the series the junction between body and antrum was measured by sampling the active gastric mucosa, 15 minutes or so after intramuscular injection of pentagastrin, with a peroral pH probe (Pye) by manipulation through the intact gastric wall. It was found that this junction lay between 5 and 7 cm from the pylorus, and the dissection resulted in the preservation of the last major branch of the nerve of Latarjet both anterior and posterior that could be seen easily by the naked eye. Assessment of patients has been by measurement of acid reduction and by clinical follow up.
Results
Insulin responses: An insulin test to 0.2 units/kg soluble insulin intravenously was carried out between the 10th and the 14th postoperative day. Interpretation was by Hollander's criteria with the exception that a positive in the first postinsulin-hour was called 'early' and in the second hour 'late'. The results are shown in Table 1 in which it is seen that of the 88 patients with satisfactory tests 61 were negative, 15 late positive and 12 early positive. Thirty-two patients who were negative have been retested at least six months later and 15 of those have converted to either a late or an early positive response, while 17 remained negative. 
